ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinomaHailong Sheng, Chuanhui Cao, Ze-Qin Guo et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 225
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activationJingyuan Sun, Dehua Wu, Mengying Shen et al.|Journal of Experimental & Clinical Cancer Research|2020Cited by 97